Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

The previous IP holders did early antiviral testing. At the time, the push was for a new generation of antibacterial drugs against resistant strains. The focus (not IPIX/CTIX) became antibacterial development as the (at the time) low hanging fruit. So, there existed evidence of antiviral efficacy before CTIX bid and won the IP.